http://www.meipharma.com
MEI Pharma, Inc. Company Intro
Pioneering new therapies for cancer.
Industry
Healthcare
MEI Pharma, Inc. Headquaters
3611 Valley Centre Drive
San Diego,92130
United States
MEI Pharma, Inc. Share price
28 Jan 2021 02:06 GMT
$3.0000
-0.03 (-0.99 %)
MEI Pharma, Inc. Market cap
$335.316 M
WMC RANKING
2021
MEI Pharma, Inc. # 203
BiotechnologyLatest MEI Pharma, Inc. News
12 Jan 2021
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Analysis highlights the impact of Covid-19 (2020-2025) | Top Players like AbbVie Inc, Celgene Corp, CTI BioPharma Corp, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc
CTI BioPharma Corp; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc; Incyte Corp; Italfarmaco SpA; JW Pharmaceutical Corp; MedImmune LLC; MEI Pharma Inc ...
12 Jan 2021
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Analysis highlights the impact of Covid-19 (2020-2025) | Top Players like AbbVie Inc, Celgene Corp, CTI BioPharma Corp, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc
CTI BioPharma Corp; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc; Incyte Corp; Italfarmaco SpA; JW Pharmaceutical Corp; MedImmune LLC; MEI Pharma Inc ...
12 Jan 2021
Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Analysis highlights the impact of Covid-19 (2020-2025) | Top Players like AbbVie Inc, Celgene Corp, CTI BioPharma Corp, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc
CTI BioPharma Corp; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc; Incyte Corp; Italfarmaco SpA; JW Pharmaceutical Corp; MedImmune LLC; MEI Pharma Inc ...
WMC Market Score
WMC Market to Revenue Score
MEI Pharma, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| MEI Pharma, Inc. | USD | $4,544 | $50,046 | $-37,513 | $3,409M | 203 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $580,590B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $353,780B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $617,950B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total MEI Pharma, Inc. Social Followers vs Top 4 Industry Competitors
MEI Pharma, Inc. Post vs Top 4 Industry Competitors
MEI Pharma, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
MEI Pharma, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
MEI Pharma, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| MEI Pharma, Inc. | 0.05 | 100 | 16.54 | 0 | 0 | 0 | 72.13 |
| Regeneron Pharmaceuticals, Inc. | 100 | 5.84 | 10.77 | 100 | 0 | 0 | 72.18 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 1.46 | 100 | 60 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 8.78 | 3.19 | 86 | 0 | 0 | 60.53 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
